A new pharmacological activity of dibutyl phthalate (DBP) on selective elimination of tumor cells from bone marrow.
DBP possesses a new pharmacological activity leading to selective deterioration of leukemic cells, with less harmful effect on the growth of normal hematopoietic progenitors.